denotes an abstract that is clinically relevant.
denotes that this is a ticketed session.
Program: ASH Poster Walks
Thursday, December 10, 2020: 2:00 PM-3:00 PM
Moderator:
Disclosures:
No relevant conflicts of interest to declare.
Panelists:
Mark Crowther, MD, St. Joseph's Hospital
,
Paul Monagle, MBBS, MSc, University of Melbourne Royal Children's Hospital
,
Janna M. Journeycake, MD, Univ. of TX Southwestern Medical Ctr. at Dallas
,
Christopher Ward, PhD, MBBChir, Royal North Shore Hospital
,
Patrick Van Dreden, PhD, Stago
,
Eric S. Mullins, MD, Cincinnati Children's Hospital Medical Center
,
Adrienne Lee, MD, Cumming School of Medicine University of Calgary
,
Camila Masias, MD, MPH, Baptist Health South Florida
,
Kenneth Jones, Harold Hamm Diabetes Center
and
Aijing Shang, MD, PhD, F. Hoffmann-La Roche Ltd
Disclosures:
No relevant conflicts of interest to declare.
The following abstracts will be featured in this session:
Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study, Patrick Van Dreden
Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy, Eric Mullins
Platelet Membrane Procoagulation in Preeclampsia, Adrienne Lee
Relapse Prediction Model for Immune-Mediated Thrombotic Thrombocytopenic Purpura, Camila Masias
Liver X Receptor (LXR) Is a Novel and Reversible Regulator of Trauma-Induced Coagulopathy, Kenneth Jones
Real-World Safety of Emicizumab: The First Interim Analysis of the European Haemophilia Safety Surveillance (EUHASS) Database, Aijing Shang
See more of: ASH Poster Walks
<< Previous Session
|
Next Session >>